Product Management and Efficacy Evaluation of an Anti-Coagulant Enoxaparin (Clexane) in Pakistan

Journal Title: Oman Medical Journal - Year 2009, Vol 24, Issue 4

Abstract

 Objective: Enoxaparin (Clexane) is a low molecular weight heparin with a molecular weight of around 4500D. It is a blood thinner used to treat pulmonary embolism, Deep vein thrombosis, unstable angina, non-ST elevated myocardial infarction and ST-segment elevation myocardial infarction. This project is designed to evaluate the most widely used Low molecular weight heparin (LMWH), enoxaparin in patients with Acute Coronary Syndrome (ACS) based on prescriptions evaluation. Methods: Prescriptions were collected from different health institutes and were evaluated on the basis of Market Share, MIP data-competitors, MIP data- indication, and on MIP data- specialty. The study included both male and female patients of age ranging between 50-70 years. The results reflect the prescription patterns of enoxaparin (Clexane) by evaluating 73 prescriptions from major cardiovascular hospitals in Pakistan between February 2008 and October 2008. Results: The prescription pattern showed that physicians in Pakistan have a tendency of prescribing enoxaparin with other drugs. The results also showed that patients were prescribed multiple anti-coagulants concomitantly, including enoxaparin and aspirin. Conclusion: Overall, the analysis of anti-coagulants has indicated that enoxaparin is the drug of choice for the treatment of ACS.

Authors and Affiliations

Shazia Alam, Syed Naqvi, Shahnaz Gauhar

Keywords

Related Articles

Relationship Between Fear of Missing Out and Academic Performance Among Omani University Students: A Descriptive Correlation Study

Objectives: Smartphones and their applications play a key role in social connections, emotion expression, information transmission, and human achievements. However, the unfavorable side of such devices can lead users to...

Gestation-wise Reference Ranges of Neutrophil Counts in Indian Newborns

Objectives: Blood counts are commonly performed tests in neonatal intensive care units with the results having various clinical ramifications. Interpreting blood counts as normal or abnormal requires reference ranges as...

In Vitro α-Amylase Inhibition and Antioxidant Activities of Methanolic Extract of Amaranthus Caudatus Linn

Objectives: The present study was aimed to investigate the α-amylase inhibition and antioxidant activities of methanolic extract of Amaranthus caudatus Linn (MeAc). Methods: Methanolic extract of Amaranthus caudatus w...

Prevalence and Determinants of Depression and Anxiety Symptoms in Surgical Patients

Objectives: Mood disorders are prevalent in hospitalized patients. However, risk factors for early diagnosis have not been studied exclusively in surgical patients. Our study aimed to investigate the prevalence and deter...

A Pilot Study Comparing Hysteroscopic Adhesiolysis by Conventional Resectoscope Versus Mini-resectoscope

Objectives: To compare the feasibility and efficacy of the mini-resectoscope with the conventional resectoscope in terms of the operative, menstrual, and reproductive outcome in hysteroscopic adhesiolysis in infertile wo...

Download PDF file
  • EP ID EP83497
  • DOI 10.5001/omj.2009.54
  • Views 58
  • Downloads 0

How To Cite

Shazia Alam, Syed Naqvi, Shahnaz Gauhar (2009). Product Management and Efficacy Evaluation of an Anti-Coagulant Enoxaparin (Clexane) in Pakistan. Oman Medical Journal, 24(4), 264-268. https://europub.co.uk/articles/-A-83497